Document Detail

Absence of estrogen and progesterone receptors in glassy cell carcinoma of the cervix.
MedLine Citation:
PMID:  9464737     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To evaluate the estrogen and progesterone receptor status of glassy cell carcinoma of the cervix to assess the possible implications of hormone replacement therapy in these patients. METHODS: The estrogen and progesterone receptor status of 13 glassy cell carcinomas was evaluated by immunohistochemistry using commercial monoclonal antibodies and a streptavidin-biotin detection system. RESULTS: No immunohistochemically detectable estrogen or progesterone receptor protein was present in tumor cells, although both receptors were identified in the adjacent normal cervical tissue. CONCLUSION: The absence of estrogen and progesterone receptors in glassy cell carcinoma suggests that this tumor would not be hormonally responsive and that these patients can be safely treated with hormone replacement therapy. Further studies are indicated to confirm this observation.
I Atlas; W Gajewski; S Falkenberry; C O Granai; M M Steinhoff
Related Documents :
7534897 - Identification and semiquantification of estrogen and progesterone receptors in pyogeni...
2759337 - Effect of progesterone on the activity of occupied nuclear estrogen receptor in vitro.
19772187 - Expression of hormonal receptor in patients with metastasizing pleomorphic adenoma of t...
12802447 - Relative binding activity of new antigestagens with progesterone receptors in human hyp...
12901627 - C-type natriuretic peptide inhibits upregulation of alpha1-adrenoceptor and inositol 1,...
6749717 - Insulin-receptor turnover and down regulation in hepatocytes.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  91     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  1998 Jan 
Date Detail:
Created Date:  1998-02-26     Completed Date:  1998-02-26     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  136-8     Citation Subset:  AIM; IM    
Department of Pathology and Laboratory Medicine, Women and Infants' Hospital, Brown University, Providence, Rhode Island 02905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Carcinoma, Adenosquamous / drug therapy,  metabolism*,  pathology
Estrogen Replacement Therapy / standards*
Middle Aged
Neoplasm Staging
Receptors, Estrogen / analysis*
Receptors, Progesterone / analysis*
Retrospective Studies
Uterine Cervical Neoplasms / drug therapy,  metabolism*,  pathology
Reg. No./Substance:
0/Receptors, Estrogen; 0/Receptors, Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Epidemiology of repeat ectopic pregnancy: a population-based prospective cohort study.
Next Document:  Identification of the ureter and dissection of the bladder pillar in laparoscopic-assisted radical v...